Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.095
+0.085 (2.12%)
Aug 6, 2026, 1:52 PM EDT - Market open
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $212.64 million as of August 6, 2026. Its market cap has increased by 531.68% in one year.
Market Cap
212.64M
Enterprise Value
111.14M
1-Year Change
531.68%
Ranking
Category
Stock Price
$4.10
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $212.64M, an increase of 1.96%. That is a compound annual growth rate of 1.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 212.64M | -33.14% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 218.90M |
| Compugen | 215.97M |
| Greenwich LifeSciences | 211.22M |
| AN2 Therapeutics | 210.33M |
| Cellectis | 203.68M |
| Galectin Therapeutics | 203.50M |
| Minerva Neurosciences | 202.66M |
| Atrium Therapeutics | 200.82M |